SBI Life Insurance Company Limited (NSE:SBILIFE)

Sage Therapeutics Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-	24,133	18,938	17,206	15,060	14,558
Depreciation & Amortization	-	-	680.02	677.91	748.96	993.98
Other Amortization	-	-	82.26	-	-	-
Other Operating Activities	-	231,334	271,519	268,677	202,710	223,224
Operating Cash Flow	-	255,467	291,219	286,560	218,519	238,776
Operating Cash Flow Growth	-	-12.28%	1.63%	31.14%	-8.48%	23.73%
Capital Expenditures	-	-1,062	-1,144	-632.02	-557.87	-1,045
Sale of Property, Plant & Equipment	-	4.6	1.91	5.78	0.6	1.34
Investment in Securities	-	-409,200	-466,487	-431,870	-332,508	-298,345
Other Investing Activities	-	193,497	155,411	130,726	117,164	106,913
Investing Cash Flow	-	-217,889	-312,213	-302,030	-216,110	-192,027
Issuance of Common Stock	-	557.9	430.51	351.49	189.97	26.49
Common Dividends Paid	-	-2,706	-2,704	-4,502	-2,500	-
Other Financing Activities	-	-	-	-	-	-0
Financing Cash Flow	-	-2,148	-2,273	-4,151	-2,310	26.49
Foreign Exchange Rate Adjustments	-	-	-	-	-	-5.93
Miscellaneous Cash Flow Adjustments	-	-0.1	0	-	-	0
Net Cash Flow	-	35,430	-23,268	-19,620	99.15	46,770
Free Cash Flow	-	254,405	290,075	285,928	217,961	237,731
Free Cash Flow Growth	-	-12.30%	1.45%	31.18%	-8.32%	23.71%
Free Cash Flow Margin	-	21.76%	21.97%	35.46%	26.29%	28.95%
Free Cash Flow Per Share	-	253.74	289.52	285.52	217.74	237.63
Cash Income Tax Paid	-	9,964	8,776	7,994	7,171	5,708
Levered Free Cash Flow	-	25,636	-1,476	-8,585	13,027	14,764
Unlevered Free Cash Flow	-	25,636	-1,419	-8,522	13,089	14,816
Change in Net Working Capital	-12,729	-9,945	14,087	20,549	-2,284	-4,562

Updated Jan 17, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.